莱美药业：2025年半年度净利润亏损约3138万元

Core Viewpoint - Laimei Pharmaceutical reported a decline in revenue and a net loss for the first half of 2025, indicating potential challenges in its financial performance [2] Financial Performance - The company's revenue for the first half of 2025 was approximately 377 million yuan, representing a year-on-year decrease of 1.19% [2] - The net profit attributable to shareholders was a loss of approximately 31.38 million yuan [2] - The basic earnings per share showed a loss of 0.0297 yuan [2]